9:01 AM ET
8-K
Investor Presentation
Inmune Bio Investor Presentation
INmune Bio filed a formal investor presentation deck and announced a Master Services Agreement with Uniphar to establish a commercialization framework for Ebstrocel. The partnership will initially focus on named-patient access in Europe and the MENA region, providing a capital-efficient infrastructure for international distribution. Additionally, the company submitted a pre-Marketing Authorisation Application to the UK MHRA for Ebstrocel.
- Counterparty
- Uniphar Durbin Ireland Limited